Klaus Lindpaintner

Vice President and Director, Roche Genetics
F. Hoffman-La Roche Ltd.

Klaus Lindpaintner graduated from Innsbruck University Medical School with a degree in Medicine and from Harvard University with a degree in Public Health. He pursued postgraduate training and specialization in Internal Medicine, Cardiology, and Genetics in the United States and Germany and holds board certifications these specialties. He practiced interventional cardiology and pursued academic research in the area of cardiovascular disease, molecular genetics, and genetic epidemiology, most recently as an Associate Professor of Medicine at Harvard Medical School. He joined Hoffman-La Roche in 1997 and serves currently as Director of the “Roche Molecular Medicine Laboratories” in Basel, and Global Head, Molecular Medicines Policy and External Affairs, coordinating the company’s efforts and activities in implementing biomarker research based on genetics, genomics, pro-teomics, and associated disciplines across the value chain from early discovery to late stage clinical trials. He has co-authored more than 200 scientific papers, and currently holds honorary and adjunct professorships at the University of London Guy’s and St. Thomas, Jiao Tong University in Shanghai, Stanford University, and the University of Vienna. He has served on numerous working groups and advisory panels for trade organizations, regulatory authorities, and non-governmental organizations on issues related to ethical and societal impact of novel technologies in biomedicine.